Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding a throat ...

In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

A recent study posted on the medRxiv* preprint server has assessed the sensitivity of antigen-based rapid diagnostic tests (Ag-RDTs). Study: Comparison of the analytical and clinical sensitivity of ...

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...

In a recent article published in the journal ACS Sensors, a group of researchers developed a rapid, non-invasive, point-of-care platform for the direct detection of severe acute respiratory syndrome ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...